McKesson Stock Buy vs Citizens Financial & PulteGroup Sell Ratings | S&P 500 Picks - News and Statistics - IndexBox
π StockStory analysts recommend McKesson (MCK) as a buy within the S&P 500 for potential positive returns.
π Citizens Financial Group (CFG) is advised against due to muted 2.6% annual revenue growth and trailing earnings per share growth of 2.5%.
π PulteGroup (PHM) receives a sell rating as its large scale limits growth potential with below-average 1.2% annual revenue increases.
π° McKesson boasts a substantial market capitalization of $88.61 billion compared to CFG's $25.55 billion and PHM's $21.52 billion.
π CFG trades at a forward price-to-book value of 1x, indicating valuation concerns relative to its peers.
π PulteGroup faces declining earnings per share growth of 7.7% annually over the last two years.
π McKesson distributes pharmaceuticals and medical supplies while offering technology solutions to healthcare providers.
π The analysis focuses on S&P 500 performance outlook for the year 2026.
- McKesson is highlighted as a stock with potential for good returns based on its long-standing operational history since 1833.
- The company operates in the healthcare sector with a massive market capitalization of $88.61 billion, suggesting stability and scale.
- McKesson provides diverse services including pharmaceutical distribution, medical supply logistics, and technology solutions to pharmacies and hospitals.
- Citizens Financial Group faces slowing growth with a muted 2.6% annual revenue growth rate over the past two years.
- CFG's net interest income growth of 5.8% over the last five years fell short of typical banking sector benchmarks.
- PulteGroup's large scale limits its growth potential relative to smaller competitors in the homebuilding industry.
- PulteGroup has experienced a decline in earnings per share of 7.7% annually over the last two years.
- Diminishing returns on capital at PulteGroup suggest that previous profit drivers are losing momentum.